Literature DB >> 30570705

MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter.

Luiz Guilherme Darrigo Júnior1, Regia Caroline Peixoto Lira2, Paola Fernanda Fedatto1, David Santos Marco Antonio3, Elvis Terci Valera1, Simone Aguiar4, José Andres Yunes4,5, Silvia Regina Brandalise5, Luciano Neder6, Fabiano Pinto Saggioro6, Aline Paixão Becker6, Ricardo Santos de Oliveira7, Hélio Rubens Machado7, Rodrigo Alexandre Panepucci8, Luiz Gonzaga Tone1, Carlos Alberto Scrideli9.   

Abstract

PURPOSES: Pilocytic astrocytoma (PA) is a low-grade neoplasm frequently found in childhood. PA is characterized by slow growth and a relatively good prognosis. Genetic mechanisms such as activation of MAPK, BRAF gene deregulation and neurofibromatosis type 1 (NF1) syndrome have been associated with PA development. Epigenetic signature and miRNA expression profile are providing new insights about different types of tumor, including PAs.
METHODS: In the present study we evaluated global miRNA expression in 16 microdissected pediatric PA specimens, three NF1-associated PAs and 11 cerebral white matter (WM) samples by the microarray method. An additional cohort of 20 PAs was used to validate by qRT-PCR the expression of six miRNAs differentially expressed in the microarray data.
RESULTS: Unsupervised hierarchical clustering analysis distinguished one cluster with nine PAs, including all NF1 cases and a second group consisting of the WM samples and seven PAs. Among 88 differentially expressed miRNAs between PAs and WM samples, the most underexpressed ones regulate classical pathways of tumorigenesis, while the most overexpressed miRNAs are related to pathways such as focal adhesion, P53 signaling pathway and gliomagenesis. The PAs/NF1 presented a subset of underexpressed miRNAs, which was also associated with known deregulated pathways in cancer such as cell cycle and hippo pathway.
CONCLUSIONS: In summary, our data demonstrate that PA harbors at least two distinct miRNA signatures, including a subgroup of patients with NF1/PA lesions.

Entities:  

Keywords:  Global expression; Neurofibromatosis type 1; Pilocytic astrocitoma; miRNA

Mesh:

Substances:

Year:  2018        PMID: 30570705     DOI: 10.1007/s11060-018-03042-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.

Authors:  Milind Ronghe; Darren Hargrave; Ute Bartels; Uri Tabori; Sucheta Vaidya; Chris Chandler; Abhaya Kulkarni; Eric Bouffet
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

2.  Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.

Authors:  L Kluwe; C Hagel; M Tatagiba; S Thomas; D Stavrou; H Ostertag; A von Deimling; V F Mautner
Journal:  J Neuropathol Exp Neurol       Date:  2001-09       Impact factor: 3.685

3.  MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.

Authors:  Cheng-Ying Ho; Eli Bar; Caterina Giannini; Luigi Marchionni; Matthias A Karajannis; David Zagzag; David H Gutmann; Charles G Eberhart; Fausto J Rodriguez
Journal:  Neuro Oncol       Date:  2012-11-15       Impact factor: 12.300

4.  Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas.

Authors:  David H Gutmann; Nicolé M Hedrick; Jun Li; Rakesh Nagarajan; Arie Perry; Mark A Watson
Journal:  Cancer Res       Date:  2002-04-01       Impact factor: 12.701

Review 5.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

6.  Pilocytic astrocytomas in children: prognostic factors--a retrospective study of 80 cases.

Authors:  Carla Fernandez; Dominique Figarella-Branger; Nadine Girard; Corinne Bouvier-Labit; Joanny Gouvernet; Armando Paz Paredes; Gabriel Lena
Journal:  Neurosurgery       Date:  2003-09       Impact factor: 4.654

7.  Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.

Authors:  Yutaka Sawamura; Yuuta Kamoshima; Tsutomu Kato; Toshihiro Tajima; Junko Tsubaki
Journal:  Jpn J Clin Oncol       Date:  2009-02-17       Impact factor: 3.019

8.  A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma.

Authors:  Christoph Burkhard; Pier-Luigi Di Patre; Danielle Schüler; Georges Schüler; M Gazi Yaşargil; Yasuhiro Yonekawa; Urs M Lütolf; Paul Kleihues; Hiroko Ohgaki
Journal:  J Neurosurg       Date:  2003-06       Impact factor: 5.115

Review 9.  MAPK pathway activation in pilocytic astrocytoma.

Authors:  David T W Jones; Jan Gronych; Peter Lichter; Olaf Witt; Stefan M Pfister
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

10.  Novel BRAF Alteration in a Sporadic Pilocytic Astrocytoma.

Authors:  Sonika Dahiya; Jinsheng Yu; Aparna Kaul; Jeffrey R Leonard; David H Gutmann
Journal:  Case Rep Med       Date:  2012-04-03
View more
  5 in total

1.  High-throughput microRNA profile in adult and pediatric primary glioblastomas: the role of miR-10b-5p and miR-630 in the tumor aggressiveness.

Authors:  Luiz Guilherme Darrigo Junior; Mirella Baroni; Régia Caroline Peixoto Lira; Silvia Teixeira; Paola Fernanda Fedatto; Vanessa Silva Silveira; Veridiana Kill Suazo; Luciana Chain Veronez; Rodrigo Alexandre Panepucci; David Santos Marco Antônio; José Andres Yunes; Silvia Regina Brandalise; Simone Dos Santos Aguiar; Luciano Neder; Ricardo Santos de Oliveira; Hélio Rubens Machado; Carlos Gilberto Carlotti; Luiz Gonzaga Tone; Elvis Terci Valera; Carlos Alberto Scrideli
Journal:  Mol Biol Rep       Date:  2020-09-04       Impact factor: 2.316

Review 2.  The comprehensive landscape of miR-34a in cancer research.

Authors:  Sijing Li; Xiaohui Wei; Jinyong He; Quanquan Cao; Danyu Du; Xiaoman Zhan; Yuqi Zeng; Shengtao Yuan; Li Sun
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

Review 3.  Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme.

Authors:  Marek Mazurek; Cezary Grochowski; Jakub Litak; Ida Osuchowska; Ryszard Maciejewski; Piotr Kamieniak
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

Review 4.  Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients.

Authors:  Viviana Tritto; Luca Ferrari; Silvia Esposito; Paola Zuccotti; Donatella Bianchessi; Federica Natacci; Veronica Saletti; Marica Eoli; Paola Riva
Journal:  Genes (Basel)       Date:  2019-11-05       Impact factor: 4.096

Review 5.  Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas.

Authors:  Till Milde; Fausto J Rodriguez; Jill S Barnholtz-Sloan; Nirav Patil; Charles G Eberhart; David H Gutmann
Journal:  Neuro Oncol       Date:  2021-10-01       Impact factor: 13.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.